 |
|
Genetic Heterogeneity of Dominant Optic Atrophy, Kjer Type
Identification of a Second Locus on Chromosome 18q12.2-12.3
John B. Kerrison, MD;
Veronique J. Arnould, MD;
Juliana M. Ferraz Sallum, MD;
M. Reza Vagefi, BA;
M. Michael Barmada, PhD;
Yingying Li, MD;
Danping Zhu, MD;
Irene H. Maumenee, MD
Arch Ophthalmol. 1999;117:805-810.
ABSTRACT
| |
Objective To evaluate a family with autosomal dominant optic atrophy, which has been previously linked to the Kidd blood group.
Design Clinical evaluation with the assessment of visual acuity, color vision, and optic nerve appearance to determine affection status. Linkage analysis using polymorphic DNA markers.
Results Visual acuities ranged from 20/20 to 6/200. Although linkage was excluded for chromosome 3q28-29, markers from chromosome 18 in the vicinity of the Kidd locus were linked to the disorder (D18S34 [maximal lod score (lodmax) of 5.38 at recombination fraction ( ) of 0.14], D18S548 [lodmax=7.26, =0.09], D18S861 [lodmax=5.32, =0.07], and D18S479 [lodmax=3.28, =0.12: ]). Multipoint linkage analysis demonstrated lod scores of greater than 3 in an approximately 3-centimorgan region flanked by D18S34 and D18S479, using 98% penetrance and a phenocopy rate of 1/50.
Conclusions Dominant optic atrophy is genetically heterogeneous, with loci assigned to chromosomes 3q28-29 and 18q12.2-12.3. Dominant optic atrophy linked to 18q shows intrafamilial variation similar to that previously reported in families linked to 3q, with visual acuities ranging from normal to legal blindness. The overall distribution of visual acuities appears more favorable with the 18q phenotype. Both phenotypes appear to have a similar rate of visual decline.
INTRODUCTION
AUTOSOMAL dominant optic atrophy (Mendelian Inheritance in Man 1655001) is a hereditary disorder characterized by bilateral insidious onset of vision loss, dyschromatopsia, central visual field defects, and optic nerve pallor.2-5 The gene is highly penetrant and has variable expressivity.
In 1983, Kivlin et al6 from the Johns Hopkins Center for Hereditary Eye Diseases, Baltimore, Md, described a large pedigree of German descent from western Maryland with autosomal dominant optic atrophy and evidence of linkage to the Kidd blood group antigen. A maximal lod score (lodmax) of 2.0 at a recombination fraction () of 0.18 was obtained using the Kidd blood group antigen, then thought to be located on chromosome 2. The clinical phenotype observed in this family has been the subject of other articles.6-7 Subsequent to this, the Kidd blood group antigen, an erythrocyte urea transporter (SLC14A1), has been reassigned to chromosome 18q12.8-9
In 1994, Eiberg and Kjer and their colleagues10-11 mapped autosomal dominant optic atrophy in 3 large Danish pedigrees to the telomeric region of 3q, which they have since refined to a 1.4-centimorgan interval within a 3-megabase yeast artificial chromosome contig.12 Subsequently, families from France,13 England,14-19 Cuba,20 and the United States21 have been reported to have this localization, designated OPA1.
The purpose of this study was to examine the original western Maryland family with polymorphic DNA markers from chromosome 3q28-29 followed, as necessary, by markers from chromosome 18.
PATIENTS AND METHODS
The clinical features of this family have been reported previously by Eliott et al7 (family III). Eighty-six members underwent clinical evaluation for the present study to determine their disease status. The clinical evaluation included best-corrected visual acuity, an assessment of color vision with Ishihara plates, and ophthalmoscopic evaluation following dilation, with attention to the optic nerve. Some patients had undergone further testing, including visual fields and fundus photography. Patients with optic nerve pallor were classified as affected in the absence of other explanatory ocular disease.
Specimens of blood were drawn from 71 family members, and informed consent was obtained in accordance with a Johns Hopkins University institutional review board–approved protocol.
Leukocyte DNA was extracted and genotyped with polymerase chain reaction–based microsatellite markers as previously described.22 Chromosome-specific markers in the regions of interest were obtained from the manufacturer (MapPairs; Research Genetics, Inc, Huntsville, Ala). Two-point linkage analysis was performed using the MLINK and ILINK programs (version 5.1) of the FASTLINK package,23-27 assuming an autosomal dominant model with a gene frequency of 0.0001, no sex difference in recombination rates, a penetrance of 98%, equal allelic frequencies, and phenocopy rates of 0 and 1/50. Multipoint analysis was performed using the VITESSE algorithm.28 Table 1 and Table 2 show marker intervals for 3q and chromosome 18 that were obtained from the location database summary map at http://cedar.genetics.soton.ac.uk (accessed April 1998).29
|
|
|
|
Table 1. Two-Point Linkage Analysis With Markers From the Distal End of 3q*
|
|
|
|
|
|
|
Table 2. Two-Point Linkage Analysis With Markers Spanning Chromosome 18*
|
|
|
RESULTS
Thirty-two living persons, 19 male and 13 female (Figure 1), were affected. Thirty affected persons underwent examination for this study; the remaining 2 had been examined previously.6-7 Participants' ages ranged from 6 to 83 years (mean, 39.9 years). Visual acuities ranged from 20/20 to 6/200, with a median of 20/40 (Figure 2). The visual acuities were similar among eyes, with 8 (27%) of 30 persons showing a difference of 2 or more Snellen lines.21 The scattergram of age vs visual acuity indicates that older persons had worse visual acuities. Longitudinal data are not presented. When the visual acuities from affected persons of this family are compared with those of affected persons from another family we have studied and those of affected persons from 26 previously reported pedigrees, all of whose disorder is linked to band 3q28-29,11, 14, 16 it appears that the overall visual acuities are better for this family ( 21 test for trend=11.7, P<.001) (Table 3).
|
|
|
|
Figure 1. Pedigree of family from western Maryland with autosomal dominant optic atrophy previously linked to the Kidd blood group locus and restudied with polymorphic DNA from chromosomes 3q28-29 and chromosome 18. Solid circles (females) and squares (males) represent affected persons. Deceased persons are indicated with a slash. Arrow indicates proband.
|
|
|
|
|
|
|
Figure 2. Scattergram plot of age vs visual acuity (better eye) for persons with autosomal dominant optic atrophy. Mean visual acuities for affected individuals for ages 20 years and younger, 21 to 40 years, 41 to 60 years, and older than 60 years are plotted at ages 10, 30, 50, and 70 years, respectively.
|
|
|
|
|
|
|
Table 3. Visual Acuities From Affected Persons of This Family, Another Family, and 26 Previously Reported Pedigrees*
|
|
|
Although most persons exhibited dyschromatopsia, 2 of them (III:18 and V:8) with optic nerve pallor had visual acuities of 20/30 or better and correctly identified all Ishihara plates shown to them. All affected persons had bilateral optic disc pallor, whether diffuse or restricted to the temporal nerve.
Assessment of the following markers, linked to OPA1, from the distal region of 3q excluded linkage in this family: D3S1601, D3S3669, D3S3642, D3S1265, and D3S1272 (Table 1).
Following this, attention was focused on chromosome 18, the location of the gene for the Kidd blood group antigen. Markers spanning chromosome 18 were typed (Table 2). By 2-point analysis, using a penetrance of 98% and a phenocopy rate of 0, linkage was initially observed with marker D18S34 (lodmax=5.38, =0.14) located at band 18q12.2-21.1. The most closely linked markers were D18S548 (lodmax=7.26, =0.09) and D18S861 (lodmax=5.32, =0.07). Changing the phenocopy rate to 0.02 slightly changed the lodmax and optimal for each marker by 2-point analysis (Table 2).
Multipoint analysis was performed using 11 markers from chromosome 18—D18S877, D18S47, D18S456, D18S57, D18S468, D18S34, D18S548, D18S861, D18S479, D18S851, and D18S64. Although penetrance was maintained at 98%, the phenocopy rate varied from 0 to 0.02 (Figure 3). Allowing for phenocopies substantially increased the lod scores between these markers. The lodmax by multipoint analysis peaked between markers D18S861 and D18S479 (lodmax=6.53). This data set suggests that the gene is located within an approximately 3-centimorgan interval flanked by D18S34 and D18S479.
|
|
|
|
Figure 3. Multipoint linkage analysis using a penetrance of 98% with a phenocopy rate of 0 and 0.02 demonstrates that the gene in this family resides in an approximately 3-centimorgan region flanked by D18S34 and D18S479. zmax indicates the maximum multipoint lod score.
|
|
|
The increase in the lodmax using a phenocopy rate of 0.02 was due to 2 persons (IV:11 and V:4) who appear to be affected, yet have inherited the normal chromosome haplotype throughout the region (Figure 4). The person designated as IV:11 is a 31-year-old woman with a visual acuity of 20/40, dyschromatopsia, and mild disc pallor in each eye. One of her sons, V:4, was 8 years old and had a visual acuity of 20/60 OD and 20/70 OS and had dyschromatopsia as well as mild disc pallor in each eye.
|
|
|
|
Figure 4. Haplotypes of the portion of pedigree that includes 2 persons (IV:11 and V:4) who appear to be affected (solid circle and square), yet have inherited the normal chromosome haplotype throughout the region (open bars).
|
|
|
COMMENT
In a previous study of this family using erythrocyte, serum, and urinary electrophoretic markers, linkage to the Kidd blood group antigen had been suggested.6 The lod score of 2.0, however, at a recombination fraction of 0.18, failed to reach the accepted threshold of 3.0 for establishing linkage. The development of polymorphic microsatellite markers has permitted the reexamination of this family using a better-defined array of genetic markers than was available in the past. The family was genotyped with markers from chromosome 3q28-29, the OPA1 locus, followed by markers from chromosome 18, the location of the gene for the Kidd blood group antigen. This study confirms that dominant optic atrophy is genetically heterogeneous.
As observed in other families with dominant optic atrophy, visual acuity in this family varied from 20/20 to legal blindness. Two persons (III:18 and IV:8) from this family had visual acuities of 20/20, consistent with previous observations4, 7, 11, 16, 21 that some affected persons may have dyschromatopsia and disc pallor with excellent visual acuity. Whereas the range of visual acuities appears similar, the overall distribution of visual acuities for this family appears to be more favorable in comparison with chromosome 3q28-29–linked families (Table 3).11, 14, 16, 21
Two longitudinal studies7, 11 have shown slow, progressive vision loss for patients with dominant optic atrophy. In a study of 3 pedigrees linked to the distal end of 3q with a mean follow-up of 14 years, Kjer et al11 reported that vision loss progressed in 20 (67%) of 30 patients and tended to be slow, although a few persons had a rapid decline in visual acuity. In a previous study of this family with a mean follow-up of 18 years, Eliott et al7 reported that acuity declined in both eyes in 5 (45%) of 11 patients (family III). On reexamination for the present study, older patients had worse vision than younger persons, suggesting that visual acuity deteriorates with age (Figure 2). This may be due to progressive ganglion cell loss from the underlying genetic defect or a phenomenon of aging.
Screening for color vision abnormalities was performed using Ishihara plates. Although these are a commonly used clinical tool, they are not optimal for identifying the acquired blue-yellow defects typical of patients with dominant optic atrophy. Two persons (III:18 and V:8) who had good visual acuity and mild disc pallor correctly identified all Ishihara plates shown to them.
Dominant optic atrophy is not completely penetrant. An estimated 2% of persons may carry a haplotype associated with the disease, have affected offspring, and yet manifest no signs of optic neuropathy.10-11 No skipped generations occurred in this family (Figure 1).
Linkage to chromosome 3q was excluded in this family, confirming that dominant optic atrophy is genetically heterogeneous. Furthermore, linkage with markers from chromosome 18q12.2-12.3 was established, constituting a second locus for dominant optic atrophy. Despite evidence of linkage, investigation of this region has failed to identify a marker. Similar results were obtained when linkage analysis was performed21 using an affected-only model because of the possibility of reduced penetrance. Our working hypothesis is that persons IV:11 and V:4 represent phenocopies. They meet criteria to be classified as affected, yet do not share the disease haplotype. Multipoint analysis, based on our data set, suggests that the gene is located in an approximately 3-centimorgan interval between D18S34 and D18S479.
This is the first dominant optic atrophy pedigree with linkage identified on chromosome 18q12.2-12.3. More than 30 pedigrees with linkage to chromosome 3q28-29 have been reported, suggesting that most cases are due to OPA1. Seller et al19 described 9 pedigrees from England, 8 of whom were linked to chromosome 3q28-29. One family showed no evidence of linkage to this locus, supporting the present finding that dominant optic atrophy is genetically heterogeneous. The chromosome 3q28-29 locus (OPA1) appears to be the predominant gene responsible for dominant optic atrophy.
CONCLUSIONS
Dominant optic atrophy is genetically heterogeneous, with loci thus far identified on chromosomes 3q and 18q. Dominant optic atrophy linked to 18q in this family shows intrafamilial variation similar to that in previously reported families linked to 3q, with visual acuities ranging from normal to legal blindness. The overall visual acuities were better with this 18q-linked family compared with previously described 3q-linked families. Both phenotypes appear to have a similar rate of visual decline.
AUTHOR INFORMATION
Accepted for publication February 8, 1999.
This study was supported in part by the Knights Templar Eye Foundation Inc, Chicago, Ill (Dr Kerrison); the Belgian American Educational Foundation, the Francqui Foundation, the Rotary Foundation, and the Vocational Foundation of Belgium, Brussels (Dr Arnould); Conselho Nacional de Desenvolvimento Científico e Tecnológico, Brasil (Dr Ferraz Sallum); and a grant from Research to Prevent Blindness Inc, New York, NY, and the Krieble and Walter Edel Funds of the Johns Hopkins Center for Hereditary Eye Diseases (Dr Maumenee).
We thank Susan Vitale, PhD, for statistical consultation.
Reprints are not available from the authors.
From the Johns Hopkins Center for Hereditary Eye Diseases, Wilmer Eye Institute, Baltimore, Md (Drs Kerrison, Arnould, Ferraz Sallum, Li, Zhu, and Maumenee, and Mr Vagefi); and the Department of Human Genetics, University of Pittsburgh School of Public Health, Pittsburgh, Pa (Dr Barmada).
REFERENCES
| |
1. McKusick VA. Mendelian Inheritance in Man: A Catalog of Human Genes and Genetic Disorders. 10th ed. Baltimore, Md: Johns Hopkins University Press; 1992.
2. Kjer P. Congenital optic atrophy with dominant mode of inheritance: a clinical and genetic study of 19 Danish families. Acta Ophthalmol. 1959;37(suppl):1-146.
3. Smith DP. Diagnostic criteria in dominantly inherited juvenile optic atrophy: a report of three new families. Am J Optom. 1972;49:183-200.
4. Kline LB, Glaser JS. Dominant optic atrophy: the clinical profile. Arch Ophthalmol. 1979;97:1680-1686.
FREE FULL TEXT
5. Hoyt CS. Autosomal dominant optic atrophy: a spectrum of disability. Ophthalmology. 1980;87:245-251.
ISI
| PUBMED
6. Kivlin JD, Lovrien EW, Bishop DT, Maumenee IH. Linkage analysis in dominant optic atrophy. Am J Hum Genet. 1983;35:1190-1195.
ISI
| PUBMED
7. Eliott D, Traboulsi EI, Maumenee IH. Visual prognosis in autosomal dominant optic atrophy (Kjer type). Am J Ophthalmol. 1993;115:360-367.
ISI
| PUBMED
8. Geitvik GA, Hoyheim B, Gedde-Dahl T, et al. The Kidd (JK) blood group locus assigned to chromosome 18 by close linkage to a DNA-RFLP. Hum Genet. 1987;77:205-209.
FULL TEXT
|
ISI
| PUBMED
9. Olives B, Mattei MG, Huet M, et al. Kidd blood group and urea transport function of human erythrocytes are carried by the same protein. J Biol Chem. 1995;270:15607-15610.
FREE FULL TEXT
10. Eiberg H, Kjer B, Kjer P, Rosenberg T. Dominant optic atrophy (OPA1) mapped to chromosome 3q region, I: linkage analysis. Hum Mol Genet. 1994;3:977-980.
FREE FULL TEXT
11. Kjer B, Eiberg H, Kjer P, Rosenberg T. Dominant optic atrophy mapped to chromosome 3q region, II: clinical and epidemiological aspects. Acta Ophthalmol Scand. 1996;74:3-7.
ISI
| PUBMED
12. Jonasdottir A, Eiberg H, Kjer B, Kjer P, Rosenberg T. Refinement of the dominant optic atrophy locus (OPA1) to a 1.4-cM interval on chromosome 3q28-3q29, within a 3-Mb YAC contig. Hum Genet. 1997;99:115-120.
FULL TEXT
|
ISI
| PUBMED
13. Bonneau D, Souied E, Gerber S, et al. No evidence of genetic heterogeneity in dominant optic atrophy. J Med Genet. 1995;32:951-953.
FREE FULL TEXT
14. Johnston RL, Burdon MA, Spalton DJ, Bryant SP, Behnam JT, Seller MJ. Dominant optic atrophy, Kjer type: linkage analysis and clinical features in a large British pedigree [published correction appears in Arch Ophthalmol. 1997;115:681]. Arch Ophthalmol. 1997;115:100-103.
FREE FULL TEXT
15. Votruba M, Moore AT, Bhattacharya SS. Genetic refinement of dominant optic atrophy (OPA1) locus to within a 2 cM interval of chromosome 3q. J Med Genet. 1997;34:117-121.
FREE FULL TEXT
16. Votruba M, Fitzke FW, Holder GE, Carter A, Bhattacharya SS, Moore AT. Clinical features in affected individuals from 21 pedigrees with dominant optic atrophy. Arch Ophthalmol. 1998;116:351-358.
FREE FULL TEXT
17. Child A, Stoiliva D, Sarfarazi M. Fine mapping of autosomal dominant optic atrophy type on 3q28-qter. Am J Hum Genet. 1995;(suppl 57):1080.
18. Stoiliva D, Child A, Desai SP, Sarfarazi M. Refinement of the locus for autosomal dominant juvenile optic atrophy to a 2 cM region on 3q28. Ophthalmic Genet. 1997;18:1-6.
ISI
| PUBMED
19. Seller MJ, Behnam JT, Lewis CM, Johnston RL, Burdon MA, Spalton DJ. Linkage studies in dominant optic atrophy, Kjer type: possible evidence for heterogeneity. J Med Genet. 1997;34:967-972.
FREE FULL TEXT
20. Lunkes A, Hartung U, Magarino C, et al. Refinement of the OPA1 gene locus on chromosome 3q28-q29 to a region 2-8 cM, in one Cuban pedigree with autosomal dominant optic atrophy type Kjer [letter]. Am J Hum Genet. 1995;57:968-970.
ISI
| PUBMED
21. Brown J Jr, Fingert JH, Taylor CM, Lake M, Sheffield VC, Stone EM. Clinical and genetic analysis of a family affected with dominant optic atrophy [published correction appears in Arch Ophthalmol. 1997;115:663]. Arch Ophthalmol. 1997;115:95-99.
FREE FULL TEXT
22. Kerrison JB, Arnould VJ, Barmada MM, Koenekoop RK, Schmeckpeper BJ, Maumenee IH. A gene for autosomal dominant congenital nystagmus localizes to 6p12. Genomics. 1996;33:523-526.
FULL TEXT
|
ISI
| PUBMED
23. Lathrop GM, Lalouel JM. Easy calculations of lod scores and genetic risks on small computers. Am J Hum Genet. 1984;36:460-465.
ISI
| PUBMED
24. Lathrop GM, Lalouel JM, Julier C, Ott J. Strategies for multilocus linkage analysis in humans. Proc Natl Acad Sci U S A. 1984;81:3443-3446.
FREE FULL TEXT
25. Lathrop GM, Lalouel JM, White RL. Construction of human linkage maps: likelihood calculations for multilocus linkage analysis. Genet Epidemiol. 1986;3:39-52.
FULL TEXT
|
ISI
| PUBMED
26. Cottingham RW Jr, Idury RM, Schaffer AA. Faster sequential linkage computations. Am J Hum Genet. 1993;53:252-263.
ISI
| PUBMED
27. Schaffer AA, Gupta SK, Shriram K, Cottingham RW Jr. Avoiding recomputation in linkage analysis. Hum Hered. 1994;44:225-237.
ISI
| PUBMED
28. O'Connell JR, Weeks DE. The VITESSE algorithm for rapid exact multilocus linkage analysis via genotype set-recoding and fuzzy inheritance. Nat Genet. 1995;11:402-408.
FULL TEXT
|
ISI
| PUBMED
29. Collins A, Frezal J, Teague J, Morton NE. A metric map of humans: 23,500 loci in 850 bands. Proc Natl Acad Sci U S A. 1996;93:14771-14775.
FREE FULL TEXT
SECTION EDITOR: EDWIN M. STONE, MD, PHD
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Inherited mitochondrial optic neuropathies
Yu-Wai-Man et al.
J. Med. Genet. 2009;46:145-158.
ABSTRACT
| FULL TEXT
Genomic rearrangements in OPA1 are frequent in patients with autosomal dominant optic atrophy
Fuhrmann et al.
J. Med. Genet. 2009;46:136-144.
ABSTRACT
| FULL TEXT
Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: a novel disorder of mtDNA maintenance
Hudson et al.
Brain 2008;131:329-337.
ABSTRACT
| FULL TEXT
Reduction of Inner Retinal Thickness in Patients with Autosomal Dominant Optic Atrophy Associated with OPA1 Mutations
Ito et al.
IOVS 2007;48:4079-4086.
ABSTRACT
| FULL TEXT
Opa1 deficiency in a mouse model of autosomal dominant optic atrophy impairs mitochondrial morphology, optic nerve structure and visual function
Davies et al.
Hum Mol Genet 2007;16:1307-1318.
ABSTRACT
| FULL TEXT
Autosomal dominant optic atrophy associated with hearing impairment and impaired glucose regulation caused by a missense mutation in the WFS1 gene.
Eiberg et al.
J. Med. Genet. 2006;43:435-440.
ABSTRACT
| FULL TEXT
Mitochondrial DNA content is decreased in autosomal dominant optic atrophy
Kim et al.
Neurology 2005;64:966-972.
ABSTRACT
| FULL TEXT
A third locus for dominant optic atrophy on chromosome 22q
Barbet et al.
J. Med. Genet. 2005;42:e1-e1.
FULL TEXT
OPA3 gene mutations responsible for autosomal dominant optic atrophy and cataract
Reynier et al.
J. Med. Genet. 2004;41:e110-e110.
FULL TEXT
Gene Expression Profiling of Purified Rat Retinal Ganglion Cells
Farkas et al.
IOVS 2004;45:2503-2513.
ABSTRACT
| FULL TEXT
Developmental Expression Profile of the Optic Atrophy Gene Product: OPA1 Is Not Localized Exclusively in the Mammalian Retinal Ganglion Cell Layer
Aijaz et al.
IOVS 2004;45:1667-1673.
ABSTRACT
| FULL TEXT
Optic disc morphology of patients with OPA1 autosomal dominant optic atrophy
Votruba et al.
Br J Ophthalmol 2003;87:48-53.
ABSTRACT
| FULL TEXT
Importance of molecular testing in dominant optic atrophy
Patel et al.
Br J Ophthalmol 2002;86:1314-1315.
FULL TEXT
A Comprehensive Survey of Mutations in the OPA1 Gene in Patients with Autosomal Dominant Optic Atrophy
Thiselton et al.
IOVS 2002;43:1715-1724.
ABSTRACT
| FULL TEXT
OPA1 mutations in patients with autosomal dominant optic atrophy and evidence for semi-dominant inheritance
Pesch et al.
Hum Mol Genet 2001;10:1359-1368.
ABSTRACT
| FULL TEXT
Spectrum, frequency and penetrance of OPA1 mutations in dominant optic atrophy
Toomes et al.
Hum Mol Genet 2001;10:1369-1378.
ABSTRACT
| FULL TEXT
The Pupil in Dominant Optic Atrophy
Bremner et al.
IOVS 2001;42:675-678.
ABSTRACT
| FULL TEXT
|
